InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Dash Barry H, Director. Officer active across 1 company, notably Elite Pharmaceuticals INC. Cumulatively, 3 disclosures have been published. Activity tracked since 30 June 2021. The latest transaction was filed on 22 November 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Barry H. Dash is a Board Member at Elite Pharmaceuticals Inc. He plays a key role in overseeing the company's operations and strategic decision-making. With experience in the pharmaceutical sector, he contributes to the strategic direction of Elite Pharmaceuticals, which focuses on developing generic drugs.